Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, ...
AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.
The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving standard therapy, ...
The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...
The device, called SPIRAL (Strategic Precision Infusion for Regional Administration of Liquid), is a thin, flexible tube designed to release medication at several points inside the brain. Courtesy NYU ...